Journal of Clinical Oncology (JCO) Podcast

Dr. Shannon Westin and her guest, Dr. Brian  Slomovitz discuss the article "Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy For Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors" recently published in the JCO and presented at the 2024 International Gynecologic Cancer Society. TRANSCRIPT The guest's disclosures can be found i...

In this JCO Article Insights episode, Subodh Selukar interviews author Dr. Robert Maki on " Combining Response and Toxicity Data to Implement Project Optimus " by Maki, et al published in the Journal of Clinical Oncology September 11, 2024. TRANSCRIPT Subodh Selukar: Welcome to this episode of JCO Article Insights . This is Subodh Selukar, JCO 's editorial fellow. Today, I am interviewing Dr. Robe...

Host Dr. Davide Soldato and Dr. Shelia Garland discuss the JCO article " Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors ." TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Dr. Davide Soldato: Hello and welcome to JCO After Hours , the podcast where w...

In this episode of JCO Article Insights, Dr. Giselle de Souza Carvalho interviews Dr. Hatem Azim and Dr. Ann partridge on their JCO article "Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy," TRANSCRIPT Giselle Carvalho: Welcome to the JCO Article Insights episode for the August issue of the Journal of Clin...

Host Dr. Davide Soldato interviews Dr. Sana Raoof to discuss the JCO article Turning the Knobs on Screening Liquid Biopsies for High-Risk Populations: Potential for Dialing Down Invasive Procedures . TRANSCRIPT Dr. Davide Soldato:  Hello, and welcome to JCO After Hours , the podcast where we sit down with others from some of the latest articles published in the Journal of Clinical Oncology . I am...

In this episode of JCO Article Insights, Rohit Singh interviews Dr. Ticiana Leal on the editorial, " Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade ." TRANSCRIPT The guests' disclosures can be found in the transcript. Dr. Rohit Singh: Hello and welcome to JCO's Article Insights . I am your host Rohit Singh and today we will be discussing the JCO article, " Back to the Drawing Bo...

Dr. Shannon Westin and her guest, Dr. Chao Cao, discuss the paper " Prevalence and Cancer-Specific Patterns of Functional Disability Among US Cancer Survivors, 2017-2022 " recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare.  Dr. Shannon Westin: Hello, everyone, and welcome to another episode of JCO After Hours , the podcast where we get in dep...

In this JCO Article Insights episode, Alexandra Rojek provides a summary on  "Anti-CD19 Chimeric Antigen Receptor T-cell therapy for Richter's Transformation: An International, Multicenter, Retrospective Study by Kittai, et al published in the Journal of Clinical Oncology March 29th, 2024.  TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Alexandra Rojek : Hello and welc...

Dr. Shannon Westin and her guest, Dr. Bryan Schneider discuss the article " ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-induced Peripheral Neuropathy in Black Women with Early Stage Breast Cancer " recently published in the JCO and presented at the 2024 ASCO Annual Meeting. TRANSCRIPT  The guest on this podcast episode has no disclosures to declare. Shannon Wes...

In this JCO Article Insights episode, Alexandra Rojek provides a summary on " Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial " by Camus et al published February 16th, 2024 and the associated editorial wri...

Dr. Shannon Westin and her guest, Dr. Patrick Stone, discuss the article, Methylphenidate Versus Placebo for Treating Fatigue in People with Advanced Cancer, a Randomized, Double-Blind, Multicenter Placebo-Controlled Trial , recently published in JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Shannon Westin: Hello, everyone, and welcome to another episode of JCO A...

JCO Editor in Chief, Dr. Jonathan Friedberg interviews Dr. Pamela Kunz, Editor in Chief of the new premier open access journal, JCO Oncology Advances . Dr. Friedberg and Dr. Kunz discuss what is to come from the journal and the benefits of an open access journal.  TRANSCRIPT Dr. Jonathan Friedberg: Hello and welcome to another episode of JCO After Hours . I'm your guest host, Jonathan Friedberg ,...

In this JCO Article Insights episode, Rohit Singh provides summary on two articles published in the April 10th issue of the Journal of Clinical Oncology. The first article, " Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04) " describes a randomized, open-label, multicenter, phase II...

Dr. Shannon Westin and her guests, Dr. Emily S. Tonorezos and Dr. Michael Halpern, discuss their article, " Myths and Presumptions About Cancer Survivorship " recently published in the JCO. TRANSCRIPT The guests on this podcast episode have no disclosures to declare.    Shannon Westin: Hello, everyone, and welcome to another episode of JCO After Hours , the podcast where we go in depth on manuscri...

In this JCO Article Insights episode, Alexandra Rojek provides a summary on two long term follow studies: "Long-Term Follow-Up of Rituximab Maintenance in Young Patients With Mantle-Cell Lymphoma Included in the LYMA Trial: A LYSA Study" by Sarkozy, et al published on December 18th, 2023 and " Long Term Follow Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Ritux...

Dr. Shannon Westin and her guests, Dr. Herbert Duvivier and Dr. Richard Schilsky, discuss the paper " Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study " published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare.  Shannon Westin: Hello, everyone, and welcome to ano...

In this JCO Article Insights episode, Giselle de Souza Carvalho provides a summary on  " Pathologic Exploration of the Axillary Soft Tissue Microenvironment and Its Impact on Axillary Management and Breast Cancer Outcomes " by Naoum, et al and " Optimization of Breast Cancer Regional Nodal Management " by Braunstein et al published in the January 10, 2024 issue in Journal of Clinical Oncology. The...

Dr. Shannon Westin and her guest, Dr. Reshma Jagsi, discuss the paper " Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA " recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare. Shannon Westin: Hello, everyone, and welcome to another episode of JCO Af...

Dr. Shannon Westin and her guests, Dr. Jeremy Davis and patient advocate Kathryn Carr, discuss the paper " Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy " recently published and printed in the JCO. TRANSCRIPT Shannon Westin: Hello, everyone, and welcome to another episode of JCO After Hours , the podcast where we get in depth on manuscripts that...

In this JCO Article Insights episode, Subodh Selukar summarized findings from the original article published in the January 2024 JCO issue: " The Importance of Low and Moderate Grade Adverse Events on Patients' Treatment Experience and Treatment Discontinuation " and accompanying editorial " Patient Experience, Adverse Event Reporting, and Clinical Trial Design ". The summary provides information...

Dr. Shannon Westin and her guest, Dr. Ash Alpert and Spencer Adams, discuss the paper "Debunking Sex and Disentangling Gender From Oncology" recently published in the JCO. TRANSCRIPT The guests on this podcast episode have no disclosures to declare. Shannon Westin: Hello and welcome to JCO After Hours , the podcast where we get in depth on manuscripts published in the Journal of Clinical Oncology...

Dr. Shannon Westin and her guests, Dr. Judy Garber and Dr. Geoffrey Oxnard, discuss the paper "Germline EGFR Mutations and Familial Lung Cancer" recently published in the JCO. TRANCRIPT The guest on this podcast episode has no disclosures to declare.    Shannon Westin: Hello, and welcome to JCO After Hours , the podcast where we get in-depth on articles that are published in the Journal of Clinica...

In this episode of JCO Article Insights, host Dr. Soldato discussed with Dr. Knikman and Dr. Cats the findings of a study that assesses the influence of fluoropyrimidine dosing based on DYPD genotype on both progression-free and overall survival.  The article , featured in the December edition of JCO, presents groundbreaking and reassuring data. Furthermore, it highlights emerging research challen...

Dr. Shannon Westin and her guest, Dr. Michael Anne Kyle and Dr. Nancy L. Keating, discuss the paper " Prior Authorization and Association With Delayed or Discontinued Prescription Fills " recently published in the JCO. TRANSCRIPT The guest on this podcast episode has no disclosures to declare.   Shannon Westin: Hello, everyone, and welcome to another episode of JCO After Hours , the podcast that g...

Dr. Shannon Westin and her guest, Dr. Nanda Horeweg and Dr. Carien Creutzberg, discuss the paper " Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer " recently published in the JCO. TRANSCRIPT   The guest on this podcast episode has no disclosures to declare. Shannon Westin : Hello everyone, and...